Oragenics Inc (0A64)

London
Currency in USD
0.29
0.00(0.00%)
Real-time Data
0A64 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.290.31
52 wk Range
0.265.11
Key Statistics
Edit
Prev. Close
1.44
Open
0.29
Day's Range
0.29-0.31
52 wk Range
0.26-5.11
Volume
-
Average Volume (3m)
4.47K
1-Year Change
-95.52%
Book Value / Share
0.17
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0A64 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Oragenics Inc Company Profile

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Product Candidate, such as Mutacin 1140 (MU1140), a molecule belonging to the novel class of antibiotics. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

Compare 0A64 to Peers and Sector

Metrics to compare
0A64
Peers
Sector
Relationship
P/E Ratio
−0.2x−1.6x−0.6x
PEG Ratio
−0.17−0.020.00
Price/Book
2.6x3.0x2.6x
Price / LTM Sales
-30.0x3.1x
Upside (Analyst Target)
-268.6%55.2%
Fair Value Upside
Unlock17.9%9.8%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

1.160
KOPN
-0.85%
1.1200
PTN
+0.90%
1.9100
TOVX
+27.33%
0.760
WWR
-5.03%
2.740
PRFX
-3.52%

FAQ

What Is the Oragenics (0A64) Stock Price Today?

The Oragenics stock price today is 0.29

What Stock Exchange Does Oragenics Trade On?

Oragenics is listed and trades on the London stock exchange.

What Is the Stock Symbol for Oragenics?

The stock symbol for Oragenics is "0A64."

What Is the Oragenics Market Cap?

As of today, Oragenics market cap is 3.62M.

What is Oragenics Earnings Per Share?

The Oragenics EPS is -4.65.

From a Technical Analysis Perspective, Is 0A64 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.